In a study focusing exclusively on G1 endometrioid carcinoma (irrespective of stage), the combination of CA-125 ≥30 U/mL and a tumor volume index ≥36 cm3 was identified as a risk factor for lymph node metastasis [9]. This evidence concerns the gene MUC16 and neoplasm.